SB 449, the "Fertility Treatment and Contraceptive Protection Act," establishes legal rights for individuals in Tennessee to access fertility treatments and contraception without state prohibition. It defines "fertility treatment" broadly to include procedures like in vitro fertilization, genetic testing of embryos, and medication for fertility, while defining "contraception" to cover methods such as birth control pills, emergency contraceptives, and sterilization. The law explicitly states that Tennessee law does not prohibit these activities, overriding conflicting state laws. This act takes effect on July 1, 2025, directly affecting all residents seeking these health services within the state.
HB 959 updates Tennessee's licensure rules for marriage and family therapists. It allows students in accredited programs to use titles like "marital therapy intern" while supervised, and clarifies that associate license holders must use "associate licensed marriage and family therapist" or "AMFT" (not implying full licensure). The bill creates specific pathways for associate licensure, requiring a 9-month exam deadline and supervised practice under approved supervisors, while defining "approved supervisor" to include AAMFT-approved professionals. These changes directly affect therapy students, trainees, and practitioners seeking licensure in Tennessee.
HB 62 authorizes Tennessee athletic trainers to use dry needling for preventing, treating, and rehabilitating athletic injuries, directly affecting licensed athletic trainers in the state. The bill requires the Board of Athletic Trainers to establish minimum competency standards that practitioners must demonstrate to safely perform dry needling. It clarifies that this practice does not constitute acupuncture under existing law. The policy change expands athletic trainers' scope of practice with specific safety safeguards, effective March 28, 2025.
SB 569 prevents pharmacies from charging administrative fees for hormonal contraceptives when a patient's insurance covers the cost and includes pharmacy benefits. It directly affects insured patients seeking hormonal contraceptives and pharmacists who previously might have charged such fees. The bill amends Tennessee law to remove language allowing pharmacies to require these fees, ensuring patients covered by insurance do not face additional costs. The law takes effect July 1, 2025, and applies to all pharmacies in Tennessee.
SB 174 amends Tennessee law to update requirements for surgical assistants seeking board registration. It adds the American Board of Surgical Assistants (ABSA) as an accepted credentialing body alongside the National Commission for Certification of Surgical Assistants, allowing applicants to maintain current ABSA credentials. The bill also removes the December 31, 2019, deadline for applicants to register based on practical experience, making registration more flexible. This change directly affects surgical assistants in Tennessee seeking state licensure, effective March 25, 2025. The law modifies Tennessee Code Annotated § 63-6-219(b)(1) and (b)(3).
HB 502 expands TennCare coverage to include diagnosis (including genetic testing) and treatment for Kleefstra syndrome, a rare genetic disorder affecting development and multiple body systems. It requires TennCare to provide this coverage in the same manner and extent as for autism spectrum disorder, Down syndrome (Trisomy 21), and other similar genetic disorders, when medically necessary. This applies to all enrolled individuals with Kleefstra syndrome and covers therapies, medications, assistive devices, and interventions aimed at improving quality of life. The law takes effect July 1, 2025, after being signed by the Governor in April 2025.
HB 1201 creates a temporary "foreign training license" for internationally licensed physicians in Tennessee who meet specific criteria. It directly affects physicians trained outside the U.S. but holding valid licenses in their home countries, requiring them to provide proof of an AMA-approved medical education, an ECFMG certificate, three years of postgraduate training (or seven years of practice), and current good standing in their home licensing country. The license is tied to a specific Tennessee healthcare employer, requiring applicants to have a job offer from that provider and restricting practice to that employer unless the board is notified of a change. After two years of active practice in Tennessee under this license, physicians may qualify for a full, unrestricted medical license. The bill takes effect July 1, 2025.
HJR 80 designates May 2025 as "National Hypertension Month" in Tennessee. The resolution urges healthcare providers, insurers, and TennCare to promote hypertension awareness and support coverage for renal denervation therapies, which treat resistant hypertension. It advocates for policy changes to improve access to innovative treatments but does not create new legal requirements. As a symbolic resolution, it encourages state-level action without mandating specific outcomes.
HB 383 requires Tennessee's health commissioner to add alpha-gal syndrome - a rare meat allergy triggered by tick bites - to the state's official list of reportable diseases by July 1, 2025. Healthcare providers must then report diagnosed cases to the Department of Health under existing rules. This bill directly affects medical professionals who will need to submit these reports and public health officials who will track the condition. The law amends Tennessee Code Titles 4, 63, and 68 to implement this change, effective March 26, 2025.
SB 282, the "Individualized Investigational Treatment Act," creates a legal framework for patients with life-threatening or severely debilitating illnesses to access personalized medical treatments (like gene therapies or vaccines tailored to their genetic profile) when standard FDA-approved options have been exhausted. It directly affects eligible patients (who must meet specific criteria including physician attestation and written informed consent) and eligible facilities (those complying with federal human subjects protections). Key provisions require detailed written consent covering all treatment options, risks, and financial liability, while clarifying that insurers, health plans, and providers are **not obligated** to cover these treatments or related costs (TCA §§ 63-6-1304(a)-(d)). The law takes effect July 1, 2025, and explicitly states that heirs cannot be held liable for unpaid treatment debts if a patient dies during treatment (TCA § 63-6-1305).
